Literature DB >> 376722

Immune response to levan. II. T independence of suppression of cross-reactive idiotypes by anti-idiotype antibodies.

C Bona, R Lieberman, S House, I Green, W E Paul.   

Abstract

Pretreatment of BALB/c mice with antisera to a cross-reactive idiotype (E109IdX) expressed on many anti-bacterial levan (BL) and anti-inulin (Inu) antibodies leads to a prolonged suppression in production of IdX-bearing molecules in response to BL immunization. There is a comparable suppression in numbers of plaque-forming cells secreting IdX-bearing anti-BL and anti-Inu molecules. Furthermore, spleen cells from anti-E109IdX pretreated mice are unable to transfer to irradiated recipients the ability to produce IdX-bearing anti-BL and anti-Inu antibodies. These results indicate that the suppressive effect is at the precursor level and not simply a clearance of antibodies bearing the IdX. Suppression of IdX production can be achieved by pretreating nu/nu BALB/c mice with anti-E109IdX antibodies. Furthermore, spleen cells from pretreated mice do not inhibit the capacity of spleen cells from normal mice transferred to irradiated recipients to produce E109IdX in response to BL. This indicates that the suppression of IdX production in the anti-BL system is T independent and probably represents direct inhibition of precursors by anti-IdX.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  The polyclonal expression of immunoglobulin variable region determinants on the membrane of B cells and their precursors.

Authors:  A Coutinho; L Forni; R R Bernabé
Journal:  Springer Semin Immunopathol       Date:  1980-08

2.  In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.

Authors:  C A Bona; A S Fauci
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

3.  Regulation of monoclonal immunoglobulin G synthesis by antiidiotypic antibody in a patient with hypogammaglobulinemia.

Authors:  F Mudawwar; Z Awdeh; K Ault; R S Geha
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

4.  Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.

Authors:  W J Koopman; R E Schrohenloher; J C Barton; E C Greenleaf
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Anti-immunoglobulin antibodies. I. Expression of cross-reactive idiotypes and Ir gene control of the response to IgG2a of the b allotype.

Authors:  C Bona; P K Mongini; K E Stein; W E Paul
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

6.  Induction of idiotope suppression in the anti-azophenylarsonate response of T-depleted A/J mice.

Authors:  T L Rothstein; R A Miller; D J Parker; E Kelly; A P Vastola; A Marshak-Rothstein
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

7.  Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones.

Authors:  C A Bona; E Heber-Katz; W E Paul
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

8.  Regulation by complementary idiotypes. Ig protects the clone producing it.

Authors:  D A Rowley; P Griffith; I Lorbach
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.